Daniel P. Barboriak
Duke University · 141 works · 8,127 citations · h-index 43
Top works
- Response assessment criteria for brain metastases: proposal from the RANO group
- Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials
- Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome.
- Diffusion-weighted and Perfusion MR Imaging for Brain Tumor Characterization and Assessment of Treatment Response
- CT Perfusion Scanning with Deconvolution Analysis: Pilot Study in Patients with Acute Middle Cerebral Artery Stroke
- Metrology Standards for Quantitative Imaging Biomarkers
- Correlation of early dynamic CT perfusion imaging with whole-brain MR diffusion and perfusion imaging in acute hemispheric stroke.
- Dural sinus thrombosis: findings on CT and MR imaging and diagnostic pitfalls.
- RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults
- Quantitative Imaging to Assess Tumor Response to Therapy: Common Themes of Measurement, Truth Data, and Error Sources
- Risk factors in patients undergoing a second aorta-coronary bypass procedure
- Serial MR Imaging of Pineal Cysts
- Screening for Cerebral Metastases with FDG PET in Patients Undergoing Whole-Body Staging of Non–Central Nervous System Malignancy
- Limbic encephalitis: comparison of FDG PET and MR imaging findings.
- MR diagnosis of Creutzfeldt-Jakob disease: significance of high signal intensity of the basal ganglia.
- Applications of the Repeatability of Quantitative Imaging Biomarkers: A Review of Statistical Analysis of Repeat Data Sets
- Creation of DICOM—Aware Applications Using ImageJ
- Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases
- Quantitative imaging biomarkers: A review of statistical methods for computer algorithm comparisons
- Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study